Skip to main content

Iran nuclear deal, Egypt in the GBI-EM, vaccine worries

Hopes of a positive start to talks on reviving the Iran nuclear deal were dampened after Iran announced plans to increase uranium enrichment, highlighting that negotiations have a long way to go. If the deal is restored, it would probably be a factor weighing on oil prices, but regional tensions probably wouldn’t ease much. Elsewhere, Egypt looks set to re-join JP Morgan’s GBI-EM later this year which could boost the local bond market but also result in further pound overvaluation. Finally, recent concerns about vaccines could slow rollout in the region, delaying economic recoveries.

Become a client to read more

This is premium content that requires an active Capital Economics subscription to view.

Already have an account?

You may already have access to this premium content as part of a paid subscription.

Sign in to read the content in full or get details of how you can access it

Register for free

Sign up for a free account to gain:

  • Unlock additional content
  • Register for Capital Economics events
  • Receive email updates and economist-curated newsletters
  • Request a free trial of our services


Get access